Deprescribing fall risk-increasing drugs in older adults: implementation challenges and a conceptual framework from the DeFRID trial and global evidence
Absetzen sturzrisikosteigernder Medikamente bei älteren Erwachsenen: Umsetzungsprobleme und konzeptioneller Rahmen aus der DeFRID-Studie und globalen Daten
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 05.11.2026 · 81 (12)
DOI: 10.1093/gerona/glag248 ↗Auf einen Blick
Eine narrative Übersichtsarbeit beschreibt Herausforderungen beim Absetzen sturzrisikosteigernder Medikamente (FRIDs) bei älteren Erwachsenen. Berichtet werden ethische, operative, methodische und kontextbezogene Hürden.
Fragestellung
Welche praktischen Herausforderungen traten in der DeFRID-Studie auf, und wie lassen sie sich in einen konzeptionellen Rahmen einordnen?
Methode
Narrative Review mit systematischen Scoping-Elementen; globale RCT-Evidenz aus PubMed, OpenAlex und Google Scholar bis Dezember 2025 plus DeFRID-Prozessdaten.
Ergebnisse
Vier Kategorien: ethisch-klinische Schwierigkeiten bei der Equipoise, Rekrutierungs- und Retentionsprobleme, methodische Komplexität der Sturzerfassung und kontextspezifische Barrieren im indischen Setting. Global: geringe Adhärenz, kurze Nachbeobachtung, restriktive Kriterien und ressourcenintensive Interventionen.
Einschränkungen
Narrative Übersichtsarbeit; keine Effektmaße berichtet.
Schlussfolgerung der Autor:innen
Das Absetzen von FRIDs bei älteren Erwachsenen wird durch ethische, operative, methodische und Provider-Patienten-Hürden erschwert; nötig sind mehrstufige Strategien mit Training, Shared Decision-Making, kontextbezogenen Leitlinien und Stakeholder-Einbindung.
Kernaussagen
- Vier Hürdenkategorien wurden für DeFRID beschrieben.
- Global berichteten RCTs geringe Adhärenz und kurze Follow-up-Zeiten.
- Die Autor:innen fordern mehrstufige Strategien für skalierbare Umsetzung.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 08.10.2026. Verfasst von Madhavi Eerike und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, AIIMS Bibinagar, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Accidental Falls, Deprescriptions. Die Arbeit nennt 61 Literaturangaben. Gefördert von: Indian Council of Medical Research, Safe and Rational Use of Medicines.
Themen: Gerontologische Pflege, Sturzprophylaxe
Abstract (Originalsprache)
Background
Deprescribing fall risk-increasing drugs (FRIDs) is essential for reducing polypharmacy and falls in older adults, yet randomized controlled trials (RCTs) face unique implementation challenges. The DeFRID study is an ongoing multi-center RCT evaluating an Assess, Review, Minimize, Optimize, and Reassess-based deprescribing intervention versus usual care in adults aged ≥60 years prescribed FRIDs. The objectives of this review are threefold: (1) to describe practical challenges encountered during a multi-center deprescribing RCT in India; (2) to propose a conceptual framework for categorizing these barriers; and (3) to contextualize DeFRID’s experience within the broader deprescribing research landscape.
Methods
We conducted a narrative review with systematic scoping elements, synthesizing global RCT evidence from PubMed, OpenAlex, and Google Scholar (inception-December 2025) with DeFRID process evaluation data. DeFRID barriers and facilitators were identified via mixed-methods (clinician KAP questionnaire and qualitative interviews), team meetings, retention logs, and Phase II RCT implementation data, thematically categorized, and then compared with global RCT challenges.
Results
DeFRID implementation revealed four challenge categories: ethical-clinical difficulties establishing equipoise for FRID withdrawal; operational barriers to recruitment and retention; methodological complexities in fall outcome ascertainment; and context-specific constraints unique to the Indian low- and middle-income countries setting—limited deprescribing guidelines, polypharmacy normalization, fragmented care coordination, and hierarchical decision-making. Global RCTs revealed substantial implementation challenges: low clinician adherence, short follow-up periods, restrictive eligibility excluding frail or cognitively impaired older adults, and resource-intensive interventions limiting scalability.
Conclusions
Deprescribing FRIDs in older adults is impeded by ethical, operational, methodological, and provider-patient challenges, necessitating multilevel strategies integrating training, shared decision-making, context-specific guidelines, and stakeholder engagement for scalable implementation. Clinical trial registration number The DeFRID trial is registered with the Clinical Trials Registry of India (CTRI/2023/12/060516) [https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=ODg1NjM=&Enc=&userName=].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, AIIMS Bibinagar, Hyderabad, Telangana, India.
- Department of General Medicine, AIIMS Bibinagar, Hyderabad, Telangana, India.
- Department of Pharmacology, JIPMER, Puducherry, India.
- Department of Pharmacology, Malabar Medical College, Calicut, Kerala, India.
- Department of Pharmacology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
- Department of Community Medicine and Family Medicine, AIIMS Bibinagar, Hyderabad, Telangana, India.
ORCID-Profile: Madhavi Eerike, Sakthivadivel Varatharajan, Priyadharsini Rajendran, Paul Mathai, Veena Nayak, Vijaya Kumar Karra, Gomathi Ramaswamy, Rekha Priyadarshini, Gerard Marshall Raj, Venugopalan Gunasekaran, Shivanand Kattimani, Rijesh Potangadi, Raghavendra Rao, Mukhyaprana Prabhu, Jerin Jose Cherian, Tanu Anand, Sowparnika Treasa Sabu, Lokesh Kumar Sharma
Förderung
- Indian Council of Medical Research
- Safe and Rational Use of Medicines
Zitieren
APA
Eerike, M., Varatharajan, S., Rajendran, P., Mathai, P., Nayak, V., Karra, V. K., Ramaswamy, G., Priyadarshini, R., Raj, G. M., Gunasekaran, V., Selvaraj, J., Selvarajan, S., Kattimani, S., Chandran, A., Potangadi, R., Padinchara Kunhipilakkandiyil, S., Puthiya Veettil, N., Rao, R., Prabhu, M., …, & Sharma, L. K. (2026). Deprescribing fall risk-increasing drugs in older adults: implementation challenges and a conceptual framework from the DeFRID trial and global evidence. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(12). https://doi.org/10.1093/gerona/glag248
Vancouver
Eerike M, Varatharajan S, Rajendran P, Mathai P, Nayak V, Karra VK, et al. Deprescribing fall risk-increasing drugs in older adults: implementation challenges and a conceptual framework from the DeFRID trial and global evidence. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026;81(12). doi:10.1093/gerona/glag248
BibTeX
@article{Eerike2026,
author = {Eerike, Madhavi and Varatharajan, Sakthivadivel and Rajendran, Priyadharsini and Mathai, Paul and Nayak, Veena and Karra, Vijaya Kumar and Ramaswamy, Gomathi and Priyadarshini, Rekha and Raj, Gerard Marshall and Gunasekaran, Venugopalan and Selvaraj, Jayachandran and Selvarajan, Sandhiya and Kattimani, Shivanand and Chandran, Anu and Potangadi, Rijesh and Padinchara Kunhipilakkandiyil, Surendran and Puthiya Veettil, Narayanan and Rao, Raghavendra and Prabhu, Mukhyaprana and Cherian, Jerin Jose and Anand, Tanu and Sabu, Sowparnika Treasa and Sharma, Lokesh Kumar},
title = {Deprescribing fall risk-increasing drugs in older adults: implementation challenges and a conceptual framework from the DeFRID trial and global evidence},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2026},
volume = {81},
number = {12},
doi = {10.1093/gerona/glag248}
}
EUVIMED